ANI Pharmaceuticals Inc (ANIP)
64.95
-0.48
(-0.73%)
USD |
NASDAQ |
Apr 25, 16:00
64.98
+0.03
(+0.05%)
After-Hours: 20:00
ANI Pharmaceuticals Price to Book Value: 3.163 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 24, 2024 | 3.185 |
April 23, 2024 | 3.22 |
April 22, 2024 | 3.195 |
April 19, 2024 | 3.188 |
April 18, 2024 | 3.144 |
April 17, 2024 | 3.188 |
April 16, 2024 | 3.192 |
April 15, 2024 | 3.228 |
April 12, 2024 | 3.256 |
April 11, 2024 | 3.316 |
April 10, 2024 | 3.260 |
April 09, 2024 | 3.264 |
April 08, 2024 | 3.291 |
April 05, 2024 | 3.294 |
April 04, 2024 | 3.308 |
April 03, 2024 | 3.274 |
April 02, 2024 | 3.248 |
April 01, 2024 | 3.304 |
March 28, 2024 | 3.366 |
March 27, 2024 | 3.393 |
March 26, 2024 | 3.386 |
March 25, 2024 | 3.388 |
March 22, 2024 | 3.388 |
March 21, 2024 | 3.375 |
March 20, 2024 | 3.318 |
Date | Value |
---|---|
March 19, 2024 | 3.304 |
March 18, 2024 | 3.292 |
March 15, 2024 | 3.213 |
March 14, 2024 | 3.216 |
March 13, 2024 | 3.224 |
March 12, 2024 | 3.240 |
March 11, 2024 | 3.220 |
March 08, 2024 | 3.282 |
March 07, 2024 | 3.248 |
March 06, 2024 | 3.204 |
March 05, 2024 | 3.181 |
March 04, 2024 | 3.234 |
March 01, 2024 | 3.270 |
February 29, 2024 | 3.294 |
February 28, 2024 | 2.935 |
February 27, 2024 | 2.918 |
February 26, 2024 | 2.933 |
February 23, 2024 | 2.879 |
February 22, 2024 | 2.831 |
February 21, 2024 | 2.726 |
February 20, 2024 | 2.761 |
February 16, 2024 | 2.824 |
February 15, 2024 | 2.722 |
February 14, 2024 | 2.653 |
February 13, 2024 | 2.602 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.239
Minimum
Jun 16 2022
4.965
Maximum
Jul 30 2019
2.574
Average
2.254
Median
Jan 06 2022
Price to Book Value Benchmarks
Ligand Pharmaceuticals Inc | 1.775 |
ADMA Biologics Inc | 10.88 |
Dentsply Sirona Inc | 1.911 |
Allogene Therapeutics Inc | 0.9424 |
Vanda Pharmaceuticals Inc | 0.4736 |
Price to Book Value Related Metrics
PE Ratio | 79.24 |
PS Ratio | 2.430 |
Price to Free Cash Flow | 11.78 |
Price | 64.95 |
Earnings Yield | 1.26% |
Market Cap | 1.369B |
Operating PE Ratio | 23.88 |
Normalized PE Ratio | 70.95 |